MBI's revenues double in 2013
The US biopesticide company, Marrone Bio Innovations (MBI - Davis, California), saw revenues more than double to $6 million in the fourth quarter of 2013 and annual sales climb by a similar rate to $14.5 million. Product sales rose by just over 70% to $5 million in the fourth quarter and by nearly 87% to $12.6 million for the full year. "We continued to broaden our sales into high-value specialty crops, launched into row crops in North America and also extended our commercial reach across the globe," says MBI's chief executive officer, Dr Pam Marrone. The company posted reduced losses during both periods compared with the previous year.